CIK: 0001855655 · Show all filings
Period: Q3 2024 (← Previous) (Next →)
Filing Date: Nov 14, 2024
Total Value ($000): $2,955,927 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | NUVALENT INC | 5,000,000 | $511,500 | 17.3% | $58.34 | +42.2% | COM | 670703107 |
| ACLX | ARCELLX INC | 4,000,000 | $334,040 | 11.3% | $35.83 | +85.9% | COMMON STOCK | 03940C100 |
| ARGX | ARGENX SE | 480,374 | $260,401 | 8.8% | $406.28 | — | SPONSORED ADR | 04016X101 |
| RVMD | REVOLUTION MEDICINES INC | 5,314,089 | $240,994 | 8.2% | $33.20 | +31.2% | COM | 76155X100 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 2,516,686 | $128,603 | 4.4% | $25.24 | +104.3% | COM | 22663K107 |
| — | MERUS N V | 2,454,917 | $122,648 | 4.1% | $57.54 | — | COM | N5749R100 |
| JANX | JANUX THERAPEUTICS INC | 2,400,574 | $109,058 | 3.7% | $45.75 | -4.9% | COM | 47103J105 |
| KURA | KURA ONCOLOGY INC | 4,331,321 | $84,634 | 2.9% | $17.57 | +15.3% | COM | 50127T109 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,440,445 | $80,266 | 2.7% | $24.85 | +13.1% | COM | 87650L103 |
| EWTX | EDGEWISE THERAPEUTICS INC | 2,789,172 | $74,443 | 2.5% | $16.56 | +20.1% | COM | 28036F105 |
| IRON | DISC MEDICINE INC | 1,497,720 | $73,598 | 2.5% | $48.64 | -3.5% | COM | 254604101 |
| PCVX | VAXCYTE INC | 627,732 | $71,731 | 2.4% | $69.25 | +30.1% | COM | 92243G108 |
| ACLX | ARCELLX INC | 800,000 | $66,808 | 2.3% | $35.83 | +85.9% | Call | 03940C100 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,895,689 | $65,877 | 2.2% | $19.51 | -16.2% | COM | 92790C104 |
| OLMA | OLEMA PHARMACEUTICALS INC | 5,503,600 | $65,713 | 2.2% | $7.68 | +66.4% | COM | 68062P106 |
| ARVN | ARVINAS INC | 2,339,961 | $57,633 | 1.9% | $36.46 | -28.4% | COM | 04335A105 |
| — | Y-MABS THERAPEUTICS INC | 4,086,346 | $53,735 | 1.8% | $14.42 | — | COM | 984241109 |
| COGT | COGENT BIOSCIENCES INC | 4,609,762 | $49,785 | 1.7% | $8.04 | +21.0% | COM | 19240Q201 |
| VERA | VERA THERAPEUTICS INC | 1,096,851 | $48,481 | 1.6% | $37.95 | 0.0% | CL A | 92337R101 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 931,480 | $46,965 | 1.6% | $46.86 | 0.0% | CLASS A ORD | 61559X104 |
| ONC | BEIGENE LTD | 200,336 | $44,977 | 1.5% | $224.51 | — | SPONSORED ADR | 07725L102 |
| IMTX | IMMATICS N.V | 3,904,862 | $44,554 | 1.5% | $10.40 | +13.9% | SHS | N44445109 |
| APGE | APOGEE THERAPEUTICS INC | 701,817 | $41,225 | 1.4% | $45.91 | +4.4% | COM | 03770N101 |
| IMVT | IMMUNOVANT INC | 1,362,827 | $38,854 | 1.3% | $33.16 | -11.1% | COM | 45258J102 |
| CGEM | CULLINAN THERAPEUTICS INC | 2,321,013 | $38,854 | 1.3% | $16.71 | +6.2% | COM | 230031106 |
| SYRE | SPYRE THERAPEUTICS INC | 1,267,581 | $37,280 | 1.3% | $27.85 | 0.0% | COM NEW | 00773J202 |
| PLRX | PLIANT THERAPEUTICS INC | 3,104,486 | $34,801 | 1.2% | $12.51 | 0.0% | COM | 729139105 |
| PCVX | VAXCYTE INC | 276,800 | $31,630 | 1.1% | $69.25 | +30.1% | Call | 92243G108 |
| KROS | KEROS THERAPEUTICS INC | 525,037 | $30,489 | 1.0% | $49.39 | 0.0% | COM | 492327101 |
| ERAS | ERASCA INC | 10,668,141 | $29,124 | 1.0% | $2.37 | +18.9% | COM | 29479A108 |
| ORKA | ORUKA THERAPEUTICS INC | 719,660 | $17,639 | 0.6% | $34.79 | 0.0% | COM | 687604108 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 919,692 | $12,278 | 0.4% | $14.46 | -8.0% | COM NEW | 46489V302 |
| CMPS | COMPASS PATHWAYS PLC | 1,160,000 | $7,308 | 0.2% | $7.96 | — | SPONSORED ADS | 20451W101 |